Elucidating mechanisms of drug-induced toxicity
暂无分享,去创建一个
[1] B. Trump,et al. Calcium‐mediated cell injury and cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] Mark W. Craven,et al. Identification of toxicologically predictive gene sets using cDNA microarrays. , 2001, Molecular pharmacology.
[3] S. Orrenius,et al. The role of calcium in the regulation of apoptosis. , 1997, Biochemical and biophysical research communications.
[4] Sue Goo Rhee,et al. Hydrogen Peroxide: A Key Messenger That Modulates Protein Phosphorylation Through Cysteine Oxidation , 2000, Science's STKE.
[5] E. Petricoin,et al. Early detection: Proteomic applications for the early detection of cancer , 2003, Nature Reviews Cancer.
[6] D. Green,et al. The Pathophysiology of Mitochondrial Cell Death , 2004, Science.
[7] Allan B. Okey,et al. Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.
[8] L. Samson,et al. Global response of Saccharomyces cerevisiae to an alkylating agent. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Waring,et al. Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds. , 2005, Current opinion in drug discovery & development.
[10] W. Trager,et al. Genetic association between sensitivity to warfarin and expression of CYP2C9*3. , 1997, Pharmacogenetics.
[11] S. Orrenius,et al. The role of Ca2+ in cell killing. , 1990, Chemical research in toxicology.
[12] Ioannis Xenarios,et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions , 2002, Nucleic Acids Res..
[13] D. Straus. 15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway , 2000 .
[14] Ken Itoh,et al. Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway , 2003, The Journal of Biological Chemistry.
[15] S. Orrenius,et al. Signal Transduction Pathways in Apoptosis , 1996, Trends in cell biology.
[16] N. Pumford,et al. Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. , 1996, Chemical research in toxicology.
[17] A. Wyllie,et al. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.
[18] D. Jollow,et al. Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. , 1990, Toxicology and applied pharmacology.
[19] J. Uetrecht,et al. Animal models of idiosyncratic drug reactions. , 2004, Chemico-biological interactions.
[20] W. Humphreys,et al. Discovering Drugs Through Biological Transformation: Role of Pharmacologically Active Metabolites in Drug Discovery , 2004 .
[21] D. Liebler. Proteomics and the New Biology , 2002 .
[22] Occupational Tumors and Allied Diseases. , 1942 .
[23] T. Ideker,et al. Integrating phenotypic and expression profiles to map arsenic-response networks , 2004, Genome Biology.
[24] W. H. Schaefer,et al. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. , 2004, Toxicology and applied pharmacology.
[25] J. Groopman,et al. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. , 1985, Carcinogenesis.
[26] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Thorgeirsson,et al. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.
[28] R. Dunn,et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[29] Kerry Blanchard,et al. Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicity. , 2004, Mutation research.
[30] H. Rosen,et al. Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic. , 1999, Science.
[31] J. Landry,et al. Activation of the p38 Signaling Pathway by Heat Shock Involves the Dissociation of Glutathione S-Transferase Mu from Ask1* , 2002, The Journal of Biological Chemistry.
[32] D. Liebler,et al. P-Mod: an algorithm and software to map modifications to peptide sequences using tandem MS data. , 2005, Journal of proteome research.
[33] John I. Clark,et al. Shotgun identification of protein modifications from protein complexes and lens tissue , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. D. Engel,et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.
[35] D. Liebler,et al. Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac. , 2003, Chemical research in toxicology.
[36] G. Natoli,et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.
[37] J A Miller,et al. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.
[38] Thomas J. Begley,et al. Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Evers,et al. Transport of the glutathione conjugate of ethacrynic acid by the human multidrug resistance protein MRP , 1996, FEBS letters.
[40] F. Oehme. Book reviewPrinciples and methods of toxicology: 3rd Edition, Edited by A. Wallace Hayes. Raven Press Ltd, 1185 Avenue of the Americas, New York, NY 10036. 1994. 1468 pp. US$125.00 , 1995 .
[41] J. Miller. Brief history of chemical carcinogenesis. , 1994, Cancer letters.
[42] T. Baillie,et al. Minimizing the potential for metabolic activation as an integral part of drug design. , 2005, Current opinion in drug discovery & development.
[43] A. Dinkova-Kostova,et al. Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. , 2004, Advances in enzyme regulation.
[44] Henrik Antti,et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.
[45] R D deShazo,et al. Allergic reactions to drugs and biologic agents. , 1997, JAMA.
[46] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.
[47] M. Pirmohamed,et al. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.
[48] E. Lock,et al. A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[49] C. Tohyama,et al. Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats. , 2002, Toxicology and applied pharmacology.
[50] George M. Church,et al. Regulatory Networks Revealed by Transcriptional Profiling of Damaged Saccharomyces cerevisiae Cells: Rpn4 Links Base Excision Repair with Proteasomes , 2000, Molecular and Cellular Biology.
[51] Ronald W. Davis,et al. Functional profiling of the Saccharomyces cerevisiae genome , 2002, Nature.
[52] R. Woosley,et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin , 1992, Clinical pharmacology and therapeutics.
[53] Johnson De,et al. Linking toxicity and chemistry: think globally, but act locally? , 2004 .
[54] T. Baillie,et al. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. , 2001, Chemical research in toxicology.
[55] W. H. Schaefer,et al. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone. , 2004, Toxicology and applied pharmacology.
[56] W. H. Jordan,et al. Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor* , 2003, Journal of Biological Chemistry.
[57] Trey Ideker,et al. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. , 2002, Molecular cancer research : MCR.
[58] M. Manns,et al. Autoantibodies against cytochromes P450: role in human diseases. , 1994, Advances in pharmacology.
[59] T R Zacharewski,et al. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[60] R. Cole,et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[61] F. Guengerich,et al. Where is Toxicology Headed in the Future? , 2004, Drug metabolism reviews.
[62] T. K. Baker,et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. , 2001, Chemical research in toxicology.
[63] J. Haselden,et al. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. , 2003, Rapid communications in mass spectrometry : RCM.
[64] Daniel C Liebler,et al. Proteomic approaches to characterize protein modifications: new tools to study the effects of environmental exposures. , 2002, Environmental health perspectives.
[65] Mark D. Johnson,et al. A gene expression signature for oxidant stress/reactive metabolites in rat liver. , 2004, Biochemical pharmacology.
[66] Robert S Plumb,et al. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. , 2002, Rapid communications in mass spectrometry : RCM.
[67] W. Pichler,et al. Delayed Drug Hypersensitivity Reactions , 2003, Annals of Internal Medicine.
[68] A. Roses,et al. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia , 2004, The Pharmacogenomics Journal.
[69] R. Weinshilboum,et al. Pharmacogenomics: bench to bedside , 2004, Nature Reviews Drug Discovery.
[70] Masayuki Yamamoto,et al. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] P. Demoly,et al. Classification and epidemiology of hypersensitivity drug reactions. , 2004, Immunology and allergy clinics of North America.
[72] E. Puré,et al. Cyclooxygenases, Thromboxane, and Atherosclerosis: Plaque Destabilization by Cyclooxygenase-2 Inhibition Combined With Thromboxane Receptor Antagonism , 2005, Circulation.
[73] S. Sherlock,et al. HALOTHANE-RELATED HEPATITIS , 1975 .
[74] Joseph F. Borzelleca. PROFILES IN TOXICOLOGY Paracelsus: Herald of Modern Toxicology , 2000 .
[75] D. Liebler. Introduction to proteomics : tools for the new biology /by Daniel C. Liebler ; foreword by John R. Yates, III. , 2007 .
[76] C. B. Pickett,et al. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. , 2003, Annual review of pharmacology and toxicology.
[77] J. Borzelleca. Paracelsus: herald of modern toxicology. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[78] Minoru Takagi,et al. Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.
[79] T. Shimada,et al. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.
[80] Andrew G Fraser,et al. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. , 2003, Genes & development.
[81] Paul Talalay,et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[82] E. Fernandez,et al. Acetaminophen Toxicity , 1977 .
[83] R G Ulrich,et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.
[84] A. Speirs. Thalidomide and congenital abnormalities. , 1962, Lancet.
[85] Michael D. Waters,et al. Toxicogenomics and systems toxicology: aims and prospects , 2004, Nature Reviews Genetics.
[86] F. Guengerich,et al. Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[87] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[88] Dean P. Jones,et al. Compartmentation of glutathione: implications for the study of toxicity and disease. , 1996, Toxicology and applied pharmacology.
[89] E. Corey,et al. Facile air oxidation of the conjugate base of rofecoxib (VioXX), a possible contributor to chronic human toxicity , 2005 .
[90] J. Rapola,et al. MATERNAL ALPHA-FETOPROTEIN AND FETAL EXOMPHALOS , 1976, The Lancet.
[91] H. Shinagawa,et al. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. , 1985, Mutation research.
[92] G. Opiteck,et al. Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.
[93] C. Glass,et al. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway , 2000 .
[94] L. Marnett,et al. IκB Kinase, a Molecular Target for Inhibition by 4-Hydroxy-2-nonenal* , 2001, The Journal of Biological Chemistry.
[95] R. Armstrong,et al. Structure, catalytic mechanism, and evolution of the glutathione transferases. , 1997, Chemical research in toxicology.
[96] D. Rader,et al. COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice , 2004, Science.
[97] Mark Hannink,et al. Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.
[98] L. Babiss,et al. Toxicogenomics in predictive toxicology in drug development. , 2004, Chemistry & biology.
[99] H. Yamazaki,et al. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[100] Hong Liu,et al. Endoplasmic Reticulum Chaperones GRP78 and Calreticulin Prevent Oxidative Stress, Ca2+ Disturbances, and Cell Death in Renal Epithelial Cells* , 1997, The Journal of Biological Chemistry.
[101] Trey Ideker,et al. Hot spots for modulating toxicity identified by genomic phenotyping and localization mapping. , 2004, Molecular cell.
[102] N. Holbrook,et al. The molecular response to reductive stress in LLC-PK1 renal epithelial cells: coordinate transcriptional regulation of gadd153 and grp78 genes by thiols. , 1997, Cell stress & chaperones.
[103] N. Sussman,et al. A direct hepatotoxic effect of valproic acid. , 1979, JAMA.
[104] A. D. Jones,et al. Protein Targets of Monocrotaline Pyrrole in Pulmonary Artery Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[105] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.
[106] Rune Matthiesen,et al. Introduction to proteomics. , 2007, Methods in molecular biology.
[107] D. Greenblatt,et al. In Vitro Prediction of the Terfenadine‐Ketoconazole Pharmacokinetic Interaction , 1994, Journal of clinical pharmacology.
[108] Francois Pognan,et al. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[109] R G Ulrich,et al. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. , 2001, Toxicology and applied pharmacology.
[110] T. Baillie,et al. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.
[111] T. Kensler,et al. Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element , 2005 .
[112] Y. Sugiyama,et al. Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil , 2004, Journal of Pharmacology and Experimental Therapeutics.
[113] B. van de Water,et al. Distinct endoplasmic reticulum signaling pathways regulate apoptotic and necrotic cell death following iodoacetamide treatment. , 1999, Chemical research in toxicology.
[114] Timothy A Bertram,et al. Identification of putative gene based markers of renal toxicity. , 2004, Environmental health perspectives.
[115] D. Liebler,et al. SALSA: a pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses. , 2001, Analytical chemistry.
[116] Jean-Claude Martinou,et al. Breaking the mitochondrial barrier , 2001, Nature Reviews Molecular Cell Biology.
[117] K. Itoh,et al. Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression* , 2003, Journal of Biological Chemistry.
[118] Michael Karin,et al. The IKK NF-κB system: a treasure trove for drug development , 2004, Nature Reviews Drug Discovery.
[119] J. Fahey,et al. Chemoprotection against cancer by phase 2 enzyme induction. , 1995, Toxicology letters.
[120] J. Waring,et al. Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. , 2002, Toxicology.
[121] S D Nelson,et al. The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[122] J. Lindon,et al. NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.
[123] Robert P Tonge,et al. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[124] A. Hayes. Principles and methods of toxicology , 1982 .
[125] M. Massiah,et al. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[126] A. Burlingame,et al. Identification of the Hepatic Protein Targets of Reactive Metabolites of Acetaminophen in Vivo in Mice Using Two-dimensional Gel Electrophoresis and Mass Spectrometry* , 1998, The Journal of Biological Chemistry.